Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Karius is a life sciences company dedicated to transforming infectious disease diagnostics through the innovative use of microbial cell-free DNA (mcfDNA) sequencing. Their flagship product, the Karius Test®, is a blood test that can non-invasively and rapidly identify over 1,000 bacteria, DNA viruses, fungi, and eukaryotic pathogens causing infections anywhere in the body. This technology is particularly impactful for diagnosing complex cases, especially in immunocompromised patients where traditional methods may be slow or invasive. Karius aims to empower clinicians with precise, actionable information to optimize antimicrobial stewardship and improve patient outcomes by enabling earlier, more targeted treatment.
The headquarters serves as the central hub for Karius's research and development, CLIA-certified and CAP-accredited laboratory operations, bioinformatics, commercial activities, and corporate administration.
The facility houses advanced genomics laboratories equipped with next-generation sequencing (NGS) platforms and sophisticated bioinformatics infrastructure necessary for processing and analyzing mcfDNA.
Karius fosters an innovative, collaborative, and mission-driven work culture. Employees are passionate about leveraging cutting-edge science to solve critical challenges in infectious disease and make a tangible difference in patients' lives. The environment is dynamic and encourages continuous learning and development.
This location is pivotal for Karius, as it centralizes the core scientific, technological, and operational expertise required to develop, perform, and commercialize the Karius Test, enabling rapid turnaround times for critical patient samples.
Karius primarily serves the United States market, with its Karius Test offered to hospitals and healthcare institutions nationwide. Sample processing is centralized at their Redwood City, CA, laboratory. While direct international office presence is not prominent, their technology and research have global implications, and they engage in collaborations and support clinical studies that may extend internationally, contributing to the global fight against infectious diseases.
900 Middlefield Road, Suite 200
Redwood City
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Karius' leadership includes:
Karius has been backed by several prominent investors over the years, including:
Karius has strengthened its executive team with key appointments in financial and commercial leadership over the past 12-18 months, indicating a focus on scaling operations and market presence.
Discover the tools Karius uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Karius commonly uses the email format combining the first initial and last name, or first name and last name separated by a dot. These are typical structures for corporate email addresses.
[first_initial][last]@kariusdx.com OR [first].[last]@kariusdx.com
Format
aford@kariusdx.com
Example
90%
Success rate
Fierce Biotech • March 20, 2024
Karius announced a $100 million Series C financing round co-led by Khosla Ventures and new investors 5AM Ventures and Gilde Healthcare. The funds will be used to expand patient access to the Karius Test, invest in R&D, and further validate its clinical utility through additional studies....more
GlobeNewswire • February 15, 2024
Karius presented new data at the 'Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR'. The study highlighted that the Karius Test detected more pathogens and infections missed by standard testing methods in immunocompromised pediatric patients, often leading to positive changes in clinical management....more
PR Newswire • October 4, 2023
Karius announced the appointments of Peter Manley as Chief Financial Officer and Desiree Hollemon as Chief Commercial Officer. These strategic hires are intended to support the company's efforts to scale operations and accelerate commercial growth of the Karius Test....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Karius, are just a search away.